Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brainstem implant offers hope for children born without hearing nerves

NCT ID NCT02310399

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This study tests an auditory brainstem implant in 20 children who are deaf because they are missing the inner ear or the nerve that carries sound to the brain. The device is surgically placed to stimulate the brainstem directly, bypassing the missing parts. Researchers will monitor safety and measure any improvements in hearing and speech over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nucleus ABI541 Auditory Brainstem Implant (a surgically implanted device that stimulates the brainstem to produce hearing sensations)
What this could lead to
If successful, this could provide a new hearing option for children who cannot benefit from cochlear implants, potentially improving their ability to perceive sound and develop speech.
What could go wrong
This is a very early feasibility study with only 20 children, so results may not apply widely. The surgery carries risks like infection or device complications, and hearing gains may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2014

Expected to finish

May 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 months to 21 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Group 1: Prelinguistic hearing loss (birth-5 years; age at implantation of ABI 18 months-5 years) • Pre-linguistic hearing loss (birth-5 yrs.; age at ABI 18 months-5yrs) with both: * MRI +/- CT evidence of one of the following: * Cochlear nerve deficiency * Cochlear aplasia or severe hypoplasia * Severe inner ear malformation * Post-meningitis ossification * When a cochlea is present or patent, lack of significant benefit from CI despite consistent use (\>6 mo.) * No or limited speech perception ability (limited to pattern perception on closed set testing materials using the CI) * Lack of progress in auditory skills development Group 2: Post-linguistic hearing loss (\<21 yrs. of age) * Post-linguistic hearing loss (\<21 yrs. of age) with: * Loss or lack of benefit from appropriate CI without the possibility for revision or contralateral implantation. Examples might include: * Post-meningitis ossification * Bilateral temporal bone fractures with cochlear nerve avulsion * Failed revision CI without benefit * Previously developed open set speech perception and auditory-oral language skills * No medical contraindications * Willing to receive the appropriate meningitis vaccinations * No or limited cognitive/developmental delays. * Strong family support * Reasonable expectations from parents/guardians including a thorough understanding: * of potential benefits and limitations of ABI * of parental role in rehabilitation * that the child may not develop spoken language as a primary communication mode or even sufficient spoken language to make significant academic progress in an aural/oral environment * Involvement in a rehabilitation program that emphasizes development of auditory skills with or without the use of supplementary visual communication. * Able to comply with study requirements including travel to investigation sites. * Informed consent for the procedure from the child's parents/legal guardian. Exclusion Criteria: For both Groups 1 and 2: * Pre- or post-linguistic child currently making significant progress with CI Even for the very young children (18 months of age with 6 months of use), nearly all children with a good auditory signal from their CI will show evidence of improvement in these metrics over time. * MRI evidence of one of the following: * normal cochlea and cochlear nerves or NF2 * brainstem or cortical anomaly that makes implantation unfeasible * Clear surgical reason for poor CI performance that can be remediated with revision CI or contralateral surgery rather than ABI. * Intractable seizures or progressive, deteriorating neurological disorder * Patients with evidence of Chiari malformation, hydrocephalus, spina bifid a * Patients with any foreseeable need for a future MRI scan * Unable to participate in behavioral testing and mapping with their CI. If this appears to be an age effect, ABI will be delayed until we can be assured that the child will be able to participate, as reliable objective measures of mapping are currently not available for mapping these devices. * Unable to tolerate general anesthesia (cardiac, pulmonary, bleeding diathesis, etc.). * Need for brainstem irradiation * Unrealistic expectations on the part of the subject/family regarding the possible benefits, risks and limitations inherent to the procedure and ABI device. * Unwilling to sign the informed consent. * Unwilling to make necessary follow-up appointments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss, bilateral (causes other than tumors) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • NYU Cochlear Implant Center

    RECRUITING

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.